Viatris’ Mylan And Apotex Lose Again Over US Bendeka Patents

ANDA Sponsors Continue To Be Barred From Launch Until 2031

 
• By Dean Rudge
  
Gavel
Viatris' Mylan and Apotex had challenged a 2020 order • Source: Shutterstock

More from Generics

More from Products